All In MedTech

Device Trial Radar · NCT07266389

Clinical Efficacy Evaluation of Supraglottic Airway Device SafeLM™ in Paediatric Population

Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Dec 2, 2025

Primary completion

Nov 30, 2026

Study completion Dec 30, 2026

Sponsor

Lead sponsor
National University of MalaysiaAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
University of Malaya
First posted
Dec 5, 2025

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Other
FDA-regulated device
No
Who can join
All sexes, from 0 years, up to 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The goal of this interventional study is to evaluate the clinical efficacy of SafeLM™, a video laryngeal mask airway device in paediatric population. The main questions it aims to answer are: 1. To determine the success rate, ease of device insertion, time for insertion, and how well the device seals the airway by measuring the oropharyngeal leak pressure (OPLP) of SafeLM™. 2. To determine the incidence of complication associated with SafeLM™ usage. 3. To study the association of glottic view with success rate and rate of complication. Participants perioperative clinical data will be collected for data analysis.

Conditions

  • Anesthesia
  • Supraglottic Airway Efficiency
  • Paediatric Airway Management

Interventions

  • SafeLM™ as the airway management device during general anaesthesiaDevice

    Appropriate size of SafeLM™ is selected for participants as manufacturer recommendation. Size 2 is for participants with body weight of 10-20 kg, recommended cuff volume to be inflated is 10 to 15 ml. Size 2.5 is for participants with body weight of 20-30 kg, recommended cuff volume to be inflated is 14 to 21 ml. Size 3 is for participants with body weight of 30-50 kg, recommended cuff volume to be inflated is 20 to 30 ml. Size 4 is for participants with body weight of 50-70 kg, recommended cuff volume to be inflated is 30 to 45 ml Size 5 is for participants with body weight of 70-100 kg, recommended cuff volume to be inflated is 40 to 60 ml. Under general anaesthesia, the device is held by the anaesthesiologist at the distal end while advancing the laryngeal mask by sliding down the palatopharyngeal curve along the midline in the mouth until the end of the mask reach the hypopharynx cavity and resistance is met, under direct real-time visualisation.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Success rate of device placement in percentageTime frame: Perioperative
  2. Oropharyngeal leak pressure (OPLP) in cmH2OTime frame: From the time of successful device placement confirmation to the time of determination of OPLP before commencement of surgery
  3. Glottic exposure gradesTime frame: At the time of completion of device placement procedure, when the distal end of the cuff reaches the hypopharyngeal cavity, resistance is met, and the cuff is inflated with appropriate volume of air as per manufacturer recommendation.

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • University of Malaya

    Kuala Lumpur, Malaysia · Recruiting

  • Universiti Kebangsaan Malaysia

    Cheras, Kuala Lumpur, Malaysia · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.